Shaw Christi Sells Kyverna Therapeutics Stock to Cover Taxes

On May 27, 2026, Shaw Christi, Executive Chairperson and Director of Kyverna Therapeutics, Inc. (KYTX), sold 4,194 shares of common stock. The shares were sold at a price of $8.59 per share, totaling $36,026.26. This transaction was executed to satisfy tax withholding obligations arising from the vesting of a restricted stock unit award for 16,634 shares. Following this transaction, Shaw Christi directly owns 66,741 shares of Kyverna Therapeutics stock. The filing was made on Form 4, and the signature date was May 29, 2026.